Podcast: Download (Duration: 1:15 — 1.7MB)
Subscribe: RSS
Hormone therapy for menopause has recently had a black box warning removed by the FDA, after the agency reexamined data originally prompting the warning and found it flawed. Wen Shen, a menopause expert at Johns Hopkins, says women still need …
Caveat emptor when it comes to hormone therapy for menopause, Elizabeth Tracey reports Read more »
Podcast: Download (Duration: 1:02 — 1.4MB)
Subscribe: RSS
The FDA has recently removed black box warnings, indicating a medication is potentially risky, from hormone therapy for menopause. The warning was originally put on in 2003 after a study seemed to show increased risks for cardiovascular disease, breast cancer …
What is the controversy around hormone therapy for menopause? Elizabeth Tracey reports Read more »
Podcast: Download (Duration: 1:06 — 1.5MB)
Subscribe: RSS
Certain hormone therapies for menopause have had black box warnings on them since 2003, following concerns arising from the Women’s Health Initiative study, which seemed to show increased risks for breast cancer and dementia. Now the FDA has removed these …
Podcast: Download (Duration: 1:11 — 1.6MB)
Subscribe: RSS
Using one of two drug combinations versus ibrutinib alone to treat chronic lymphocytic leukemia, one of the most common types of leukemia in adults, may allow people to avoid continuous treatment, a new study finds. William Nelson, director of the Kimmel …
Podcast: Download (Duration: 1:00 — 1.4MB)
Subscribe: RSS
For people who’ve had colorectal cancer, celecoxib, a commonly prescribed medicine for pain, may help avoid disease recurrence, a recent analysis of a larger study found. Kimmel Cancer Center director William Nelson at Johns Hopkins explains that the presence of …
